Q32 Bio Inc.
QTTB
$5.94
$0.132.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -113.18% | 881.30% | 22.13% | 13.98% | 22.26% |
| Total Depreciation and Amortization | 0.00% | -1.10% | 0.00% | -23.53% | -0.83% |
| Total Amortization of Deferred Charges | -10.81% | -19.57% | -6.12% | 2.08% | -2.04% |
| Total Other Non-Cash Items | 102.68% | -4,886.13% | -33.60% | 230.97% | -62.48% |
| Change in Net Operating Assets | -198.95% | -111.26% | 150.98% | -48.81% | -328.44% |
| Cash from Operations | -2.64% | -46.10% | 60.29% | 14.67% | -9.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.06% | 0.06% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 663.19% | 0.06% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 430.73% | 87.19% | 45.61% | 14.67% | -12.32% |